NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $122,908 | -68.9% | 174,859 | +0.0% | 0.00% | – |
Q4 2022 | $395,103 | -28.6% | 174,824 | +1.2% | 0.00% | -100.0% |
Q3 2022 | $553,000 | -18.0% | 172,816 | -2.7% | 0.00% | 0.0% |
Q2 2022 | $674,000 | -39.4% | 177,598 | -14.0% | 0.00% | 0.0% |
Q1 2022 | $1,112,000 | -52.9% | 206,513 | +18.1% | 0.00% | 0.0% |
Q4 2021 | $2,363,000 | -29.4% | 174,899 | -6.2% | 0.00% | -50.0% |
Q3 2021 | $3,348,000 | +12.3% | 186,370 | +7.2% | 0.00% | 0.0% |
Q2 2021 | $2,982,000 | -29.0% | 173,868 | -17.2% | 0.00% | 0.0% |
Q1 2021 | $4,200,000 | +2.5% | 210,036 | -12.8% | 0.00% | 0.0% |
Q4 2020 | $4,096,000 | -69.9% | 240,989 | -70.6% | 0.00% | -75.0% |
Q3 2020 | $13,594,000 | -39.7% | 819,342 | -15.9% | 0.01% | -50.0% |
Q2 2020 | $22,559,000 | +4.9% | 974,091 | -19.2% | 0.02% | -15.8% |
Q1 2020 | $21,514,000 | +48.1% | 1,205,226 | +79.0% | 0.02% | +72.7% |
Q4 2019 | $14,530,000 | +0.2% | 673,138 | -15.4% | 0.01% | -8.3% |
Q3 2019 | $14,497,000 | -28.5% | 795,920 | +39.6% | 0.01% | -33.3% |
Q2 2019 | $20,289,000 | +27.4% | 570,271 | +20.3% | 0.02% | +20.0% |
Q1 2019 | $15,927,000 | +2.1% | 474,057 | -0.1% | 0.02% | -6.2% |
Q4 2018 | $15,599,000 | -48.1% | 474,553 | -3.7% | 0.02% | -40.7% |
Q3 2018 | $30,039,000 | +34.1% | 492,780 | +7.4% | 0.03% | +22.7% |
Q2 2018 | $22,403,000 | -46.2% | 458,795 | +17.0% | 0.02% | -43.6% |
Q1 2018 | $41,653,000 | +106.5% | 391,985 | +16.0% | 0.04% | +116.7% |
Q4 2017 | $20,172,000 | +129.3% | 337,785 | -7.8% | 0.02% | +100.0% |
Q3 2017 | $8,796,000 | +52.9% | 366,506 | +24.6% | 0.01% | +50.0% |
Q2 2017 | $5,751,000 | -29.2% | 294,143 | -15.0% | 0.01% | -14.3% |
Q1 2017 | $8,120,000 | +24.7% | 345,962 | -34.8% | 0.01% | +16.7% |
Q4 2016 | $6,513,000 | -24.1% | 530,820 | +6.2% | 0.01% | -25.0% |
Q3 2016 | $8,586,000 | +24.4% | 499,783 | +3.0% | 0.01% | 0.0% |
Q2 2016 | $6,903,000 | +28.0% | 485,144 | +23.7% | 0.01% | +33.3% |
Q1 2016 | $5,391,000 | -21.6% | 392,090 | -3.9% | 0.01% | -25.0% |
Q4 2015 | $6,876,000 | +50.7% | 408,152 | -1.9% | 0.01% | +60.0% |
Q3 2015 | $4,562,000 | -44.9% | 416,133 | -37.1% | 0.01% | -37.5% |
Q2 2015 | $8,276,000 | +64.8% | 661,580 | +44.9% | 0.01% | +60.0% |
Q1 2015 | $5,021,000 | -36.7% | 456,490 | -10.8% | 0.01% | -28.6% |
Q4 2014 | $7,935,000 | +71.8% | 511,919 | +33.8% | 0.01% | +75.0% |
Q3 2014 | $4,620,000 | +21.8% | 382,722 | +29.4% | 0.00% | +33.3% |
Q2 2014 | $3,792,000 | +17.3% | 295,817 | +10.9% | 0.00% | 0.0% |
Q1 2014 | $3,233,000 | +4.1% | 266,857 | -2.5% | 0.00% | 0.0% |
Q4 2013 | $3,105,000 | +54.4% | 273,635 | +42.1% | 0.00% | +50.0% |
Q3 2013 | $2,011,000 | -60.3% | 192,599 | -56.1% | 0.00% | -60.0% |
Q2 2013 | $5,068,000 | +11.5% | 438,791 | +6.2% | 0.01% | 0.0% |
Q1 2013 | $4,545,000 | – | 413,235 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
CM Management, LLC | 35,000 | $595,000 | 0.55% |
OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |